Frazier Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-20,316
| Closed | -$1.12M | – | 1 |
|
|
2022
Q2 | $1.12M | Sell |
20,316
-34,338
| -63% | -$1.8M | 100% | 1 |
|
|
2022
Q1 | $1.75M | Sell |
54,654
-1,210,207
| -96% | -$34.7M | 88.13% | 1 |
|
|
2021
Q4 | $27.5M | Buy |
1,264,861
+460,194
| +57% | +$10.1M | 2.12% | 19 |
|
|
2021
Q3 | $17.6M | Buy |
804,667
+601,864
| +297% | +$12M | 1.41% | 23 |
|
|
2021
Q2 | $3.95M | Hold |
202,803
| – | – | 0.36% | 30 |
|
|
2021
Q1 | $3.49M | Hold |
202,803
| – | – | 0.28% | 31 |
|
|
2020
Q4 | $3.25M | Hold |
202,803
| – | – | 0.25% | 30 |
|
|
2020
Q3 | $2.16M | Hold |
202,803
| – | – | 0.19% | 26 |
|
|
2020
Q2 | $2.45M | Hold |
202,803
| – | – | 0.22% | 22 |
|
|
2020
Q1 | $1.99M | Hold |
202,803
| – | – | 0.23% | 24 |
|
|
2019
Q4 | $2.78M | Hold |
202,803
| – | – | 0.47% | 18 |
|
|
2019
Q3 | $3.17M | Hold |
202,803
| – | – | 0.99% | 15 |
|
|
2019
Q2 | $4.54M | Hold |
202,803
| – | – | 1.16% | 15 |
|
|
2019
Q1 | $13.9M | Hold |
202,803
| – | – | 3.34% | 9 |
|
|
2018
Q4 | $10.7M | Hold |
202,803
| – | – | 2.76% | 9 |
|
|
2018
Q3 | $13.8M | Hold |
202,803
| – | – | 2.53% | 9 |
|
|
2018
Q2 | $24M | Hold |
202,803
| – | – | 4.97% | 7 |
|
|
2018
Q1 | $16.8M | Hold |
202,803
| – | – | 2.79% | 7 |
|
|
2017
Q4 | $30.3M | Hold |
202,803
| – | – | 4.91% | 6 |
|
|
2017
Q3 | $12.6M | Hold |
202,803
| – | – | 4.48% | 7 |
|
|
2017
Q2 | $9.49M | Hold |
202,803
| – | – | 4.86% | 7 |
|
|
2017
Q1 | $12.4M | Buy |
202,803
+148,148
| +271% | +$8.61M | 6.63% | 5 |
|
|
2016
Q4 | $3.26M | Hold |
54,655
| – | – | 4.1% | 6 |
|
|
2016
Q3 | $3.98M | Hold |
54,655
| – | – | 1.95% | 7 |
|
|
2016
Q2 | $4.35M | Hold |
54,655
| – | – | 3.47% | 8 |
|
|
2016
Q1 | $14.7M | Hold |
54,655
| – | – | 9.07% | 6 |
|
|
2015
Q4 | $32.9M | Buy |
+54,655
| New | +$37M | 13.75% | 3 |
|
Other funds holding SRRA
Frazier Management's SRRA Position: Q3 2022 in Review
Frazier Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 20,316 shares — an estimated $1.12M sold.
Frazier Management first reported a position in SRRA in Q4 2015 and held it in 27 quarters. The position peaked at $32.9M in Q4 2015. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.
- Frazier Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Frazier Management sold 20,316 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $1.12M.
- Frazier Management first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2015 and held it in 27 quarters.
- Frazier Management's Sierra Oncology, Inc. Common Stock position peaked at $32.9M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.
Based on Frazier Management's 13F filing for Q3 2022.